<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01120574</url>
  </required_header>
  <id_info>
    <org_study_id>PR05/05/2007</org_study_id>
    <nct_id>NCT01120574</nct_id>
  </id_info>
  <brief_title>Home Mechanical Ventilation in Patients With Chronic Obstructive Pulmonary Disease (COPD) and Hypercapnic Response</brief_title>
  <official_title>Home Mechanical Ventilation in Patients With Chronic Obstructive Pulmonary Disease (COPD) Who Develop Nocturnal Hypercapnic Response Associated to Oxygen Therapy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this study is to evaluate the clinical benefits of home mechanical
      ventilation associated to oxygen therapy in COPD patients with chronic respiratory failure
      (CRF) who develop hypercapnia and nocturnal respiratory acidosis secondary to oxygen
      administration.

      We will include clinically stable COPD patients with hypercapnic CRF who develop a nocturnal
      hypercapnic response to oxygen (PaCO2 increase on awakening, at night with oxygen, &gt;10 mmHg
      respect to PaCO2 breathing room air and awake). Obstructive sleep apnoea syndrome (OSAS) will
      previously have been excluded.

      Patients will be admitted to the Pneumology ward where a nocturnal pulsioxymetry breathing
      oxygen therapy will be performed. Arterial blood gas samples will be taken at awakening
      (7AM).

      Patients who develop a hypercapnic response to oxygen will be randomised into 2 treatment
      groups:

        -  Oxygen therapy group

        -  Home mechanical ventilation plus oxygen therapy group Home mechanical ventilation will
           be performed with a bilevel pressure ventilator. Functional respiratory variables as
           well as quality of life and sleep at onset and after 6 months treatment will be
           compared.

      The principal outcome will be the evolution of arterial blood gases (PaCO2) between the two
      groups.
    </textblock>
  </brief_summary>
  <overall_status>Withdrawn</overall_status>
  <start_date type="Actual">October 2005</start_date>
  <completion_date type="Actual">December 2015</completion_date>
  <primary_completion_date type="Actual">December 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Arterial pressure of CO2.</measure>
    <time_frame>Six months</time_frame>
    <description>Follow up of its evolution comparing patients under O2 treatment and patients under O2 + non invasive ventilation treatment.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Functional respiratory tests.</measure>
    <time_frame>Six months</time_frame>
    <description>Evolution during a follow up of 6 months between both groups (O2 vs O2+NIV).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life related to health</measure>
    <time_frame>6 months</time_frame>
    <description>Evolution during a follow up of 6 months between both groups (O2 vs O2+NIV).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Nocturnal hypoventilation (nocturnal pulseoxymetry)</measure>
    <time_frame>6 months</time_frame>
    <description>Evolution during a follow up of 6 months between both groups (O2 vs O2+NIV).</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">0</enrollment>
  <condition>Chronic Obstructive Pulmonary Disease</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Oxygen therapy group.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Home mechanical ventilation plus oxygen therapy group.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Home mechanical ventilation</intervention_name>
    <description>Home mechanical ventilation will be performed with a bilevel pressure ventilator.</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Elderly patients &lt; 80 years old.

          -  COPD (ERS/ATS (FEV1 &lt; 80%, FEV1/FVC &lt; 70%, TLC &gt; 80%)).

          -  Oxygen therapy indication (PaO2 &lt; 55 mmHg or 55-59 associated to pulmonary arterial
             hypertension, chronic Cor Pulmonale, Chronic Heart failure, arrhythmias or
             polyglobulia).

          -  PaCO2 &gt; 50 mm Hg.

          -  Clinically stable at least prior to one month.

          -  Hypercapnic response: increasing PaCO2 &gt; 10 mmHg at 7 a.m after all night with oxygen
             compared with PaCO2 when awake and without oxygen therapy.

        Exclusion Criteria:

          -  Active smoker.

          -  Bronchiectasis or tuberculous after-effects.

          -  Chronic respiratory failure secondary to thorax cage or neuromuscular diseases.

          -  BMI &gt; 35 kg/m2

          -  OSAS.

          -  Locomotor system problems that disable 6 minutes walking test execution.

          -  Patients with tracheostomy.

          -  Other serious comorbidity (i.e chronic heart failure functional class &gt; II NYHA,
             cancer or chronic renal failure that requires dialysis.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Fundació Institu de Recerca de l'Hospital de la Santa Creu i Sant Pau</name>
      <address>
        <city>Barcelona</city>
        <zip>08025</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 19, 2010</study_first_submitted>
  <study_first_submitted_qc>May 10, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 11, 2010</study_first_posted>
  <last_update_submitted>March 21, 2017</last_update_submitted>
  <last_update_submitted_qc>March 21, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 22, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Nocturnal hypercapnic response to oxygen</keyword>
  <keyword>Home mechanical ventilation</keyword>
  <keyword>COPD</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Diseases</mesh_term>
    <mesh_term>Lung Diseases, Obstructive</mesh_term>
    <mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
    <mesh_term>Hypercapnia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

